Table 4:
Liver-related clinical outcomes
| All patients (N = 998) | Previously on UDCA (n = 50) | Currently on UDCA (n = 890) | Never on UDCA (n = 58) | |
|---|---|---|---|---|
| Ascites | 45 (4.5) | 4 (8.0) | 40 (4.5) | 1 (1.7) |
| Esophageal varices | 71 (7.1) | 7 (14.0) | 62 (7.0) | 2 (3.4) |
| Encephalopathy | 29 (2.9) | 2 (4.0) | 27 (3.0) | 0 (0.0) |
| Jaundice | 40 (4.0) | 3 (6.0) | 35 (3.9) | 2 (3.4) |
| HCC* | 13 (1.4) | 2 (4.3) | 10 (1.2) | 1 (1.9) |
* n = 949 (UDCA groups: n = 46, n = 851, n = 52)
Total liver transplantation in cohort (n = 36), total deaths (n = 14)
UDCA = Ursodeoxycholic acid; LT = Liver transplantation; HCC = Hepatocellular carcinoma